baber/WOPTO huggingface dataset:
Patent NZ-239283-A (NZ)
Title: Mobile cellular radio: handoff between half rate and full rate channels according to estimated received signal quality
Inventor: UDDENFELDT JAN
IPC: H04B7/26
Filed: 1991-08-06
Abstract: In a cellular mobile telephone system of the type having TDMA channels, a plurality of mobile station operate at either a full rate or a half rate. If the mobile stations are operating on the periphery of a cell they are assigned to full rate channels. If the mobile stations are operating in the vicinity of the base station, they are assigned to half rate channels. The mobile station are reassigned from full rate to half rate channels depending upon a measured parameters relating to signal strength or quality, such as the bit error rate of communications between the mobile station and the base station. If the measured bit error rate between the mobile station and a neighboring station is less than the bit error rate between the mobile station and its presently assigned base station, the mobile station is handed off to the neighboring base station.
Patent NZ-241446-A (NZ)
Title: Peptides for treating septic shock
Inventor: PORRO MASSIMO
IPC: C07K16/00
Filed: 1992-01-29
Abstract: The present invention provides methods of using peptides of the formula R1-(A-B-C)n-R, wherein R1 and R are independently H or an amino acid residue or a fatty acid residue; A is an amino acid residue selected from the group consisting of Lys and Arg; B is an amino acid selected from the group consisting of Phe, Tyr, and Trp; C is an amino acid selected from the group consisting of Leu, Ile and Val; n is an integer of 1-100. The peptides are used for the removal of endotoxin from blood or sera; the detoxification of bacterial endotoxin; and the prevention of the contamination of products with endotoxin.
Patent NZ-241928-A (NZ)
Title: Various diaza ,triaza and thiaza heterocyclic derivatives and pharmaceutical compositions
Inventor: HIMMELSBACH FRANK
IPC: C07D211/58
Filed: 1992-03-11
Abstract: The invention relates to cyclic urea derivatives of general formula    <IMAGE>  (I)  wherein Ra, Rb, X and Y are as defined herein, pharmaceutical compositions containing the derivatives and processes for preparing them.
Patent NZ-245267-A (NZ)
Title: Plug for metallurgical casting vessel; has a thermocouple within an axial channel disposed in a rib that terminates eccentrically in front of a plug cap
Inventor: LAX HERMANN
IPC: B22D41/18
Filed: 1992-11-25
Abstract: The invention relates to a refractory stopper for a metallurgical vessel used in casting. The stopper 5, which can have a central axial channel 5b, has an axial channel 5d which ends eccentrically before the stopper cap 5a and is situated in an axially extending rib 5c formed integrally on the stopper 5. Accommodated in this other axial channel 5d is a thermocouple 6 with its instrument leads.
Patent NZ-253881-A (NZ)
Title: N-(1-substituted indolylalkyl)urea and c2-5 alkanoic acid amide derivatives; pharmaceutical compositions
Inventor: IKEDA TAKAFUMI
IPC: A61K31/40
Filed: 1993-06-10
Abstract: Certain novel indoline derivatives having the ability to inhibit the 5-lipoxygenase enzyme and having formula (I) wherein R1 is C1-C4 alkyl or -NR2R3; R2 and R3 are each, independently, hydrogen or C1-C4 alkyl; R4 is C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, aryloxy C2-C4 alkyl,  arylthio C2-C4 alkyl, arylamino C2-C4 alkyl, arylsulfinyl C2-C4 alkyl, aryl, aryl C1-C6 alkyl, aryloxyaryl C1-C6 alkyl or arylthioaryl C1-C6 alkyl, and the aryl groups in the said aryloxyalkyl, arylthioalkyl, arylaminoalkyl, arylsulfinylalkyl, aryl, arylalkyl, aryloxyarylalkyl and arylthioarylalkyl may be substituted up to the maximal number of substituents and the substituents are each independently, selected from the group consisting of halo, cyano, C1-C5 alkyl, C2-C6 alkenyl, C1-C5 alkoxy, C2-C6 alkenyloxy, C2-C6 alkoxyalkyl, halosubstituted C1-C4 alkyl, halosubstituted C1-C4 alkoxy, C2-C5 alkoxycarbonyl, aminocarbonyl and C1-C4 alkylthio; A is C1-C6 alkylene, C3-C6 alkenylene or -O-(CH2)m-; Y is each independently, halogen, halosubstituted C1-C6 alkyl, C1-C6 alkyl, C2-C6 alkenyl, C1-C6 alkoxy or C3-C8 alkenyloxy;  m is 2, 3 or 4; n is 0, 1, 2 or 3; and provided that the substituent Y, if present, and the linking group A are attached to the aromatic ring. These compounds are useful in the treatment of alleviation of inflammatory diseases, allergic conditions and cardiovascular diseases in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions.
Patent NZ-255889-A (NZ)
Title: Wrapped disposable absorbent article forms an upwardly cupped shape after unwrapping
Inventor: MUCKENFUHS DELMAR RAY
IPC: A61F13/15
Filed: 1993-08-25
Abstract: An article of manufacture is disclosed for absorbing liquids, particularly body fluids such as menses. The disclosed article is disposable and has a wrapper associated therewith. An elastic material is secured to the backsheet and is maintained in a substantially tensioned state until separation of the wrapper from the backsheet. Upon separation of the wrapper from the backsheet the tension in the elastic member is released causing the disposable absorbent article to form an upwardly cupped configuration to conform more closely to the wearer's body.
Patent NZ-257172-A (NZ)
Title: Suspendable plant cultivation bag with holes, is retained by a dish
Inventor: HAWKINS DAVID NEIL
IPC: A01G9/02
Filed: 1993-10-27
Abstract: PCT No. PCT/GB93/02211 Sec. 371 Date Jul. 5, 1995 Sec. 102(e) Date Jul. 5, 1995 PCT Filed Oct. 27, 1993 PCT Pub. No. WO94/09614 PCT Pub. Date May 11, 1994A vertically extending column of soil is supported by a suspendable bag structure. This includes multiple cylindrical walls (12, 14, 18; 112, 114) the innermost one being of mesh or net. In use, openings (20; 120) are formed through the walls, for plants to grow through. The bottom of the wall assembly is within a dish (22; 122) for retaining water.
Patent NZ-259585-A (NZ)
Title: Optically active beta-aminoalkoxyborane complex, use thereof in preparation of optically active alcohol compounds
Inventor: KASHIHARA HIROSHI
IPC: C07C/
Filed: 1994-01-17
Abstract: 1. An optically active  beta -aminoalkoxyborane complex of the formula (I):    <IMAGE>  (I)  wherein R1 is C1-C8 alkyl, C3-C7 cycloalkyl, C7-C11 aralkyl or C6-C10 aryl, R2 is hydrogen, C1-C8 alkyl, C3-C7 cycloalkyl or C7-C11 aralkyl, or R1 and R2 together form (CH2)n wherein n is 3 or 4, and Ar is naphthyl, anthryl or phenanthryl, which may be substituted by from 1 to 3 substituents selected from the group consisting of halogen, nitro, C1-C6 alkyl, C3-C7 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C7-C11 aralkyl, C6-C10 aryl, C1-C6 alkoxy and styrene polymer substituents.
Patent NZ-261180-A (NZ)
Title: Coder/decoder for background sounds in digital telephony
Inventor: BERGSTROM ROLF ANDERS
IPC: G10L25/78
Filed: 1994-01-17
Abstract: A method and apparatus for encoding/decoding of background sounds. The background sounds are encoded/decoded in a digital frame based speech encoder/decoder. First, it is determined whether the signal that is directed to the encoder/decoder represents primarily speech or background sounds. When the signal directed to the encoder/decoder represents primarily background sounds, the temporal variation between consecutive frames and/or the domain of at least one filter defining parameter is restricted.
Patent NZ-285286-A (NZ)
Title: Enzymatically active subtilisin lacking the high affinity calcium binding site and has further deletion, addition and/or substitution mutants which enhances the stability of the protein
Inventor: BRYAN PHILIP N
IPC: C12N15/57
Filed: 1995-04-28
Abstract: Novel calcium free subtilisin mutants are taught, in particular subtilisins which have been mutated to eliminate amino acids 75-83 and which retain enzymatic activity and stability. Recombinant methods for producing same and recombinant DNA encoding for such subtilisin mutants are also provided.
Patent NZ-305869-A (NZ)
Title: 2-[4-[4-[4-[[2-(triazolyl-alkyl or imidazolyl-alkyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl] -2,4-dihydro-3h-1,2,4-triazol-3-one derivatives, intermediates and medicaments
Inventor: HEERES JAN
IPC: C07D405/14
Filed: 1996-04-12
Abstract: The present invention concerns novel compounds of formula (I).wherein R1 is C1-10alkyl, C3-7cycloalkyl or C1-6alkyl substituted with C3-7cycloalkyl; R2 is hydrogen or C1-6alkyl; Alk represents C1-3alkanediyl; -A- represents a bivalent radical of formula -CH=CH-N=CH- (a), -N=CH-N=CH- (b), -CH=N-N=CH- (c), -CH=CH-CH=N- (d); in said bivalent radicals a hydrogen atom may be replaced by C1-6alkyl; and Ar is unsubstituted phenyl; phenyl substituted with up to two substituents selected from halo, C1-6alkyl or C1-6alkyloxy; unsubstituted naphthyl; or naphthyl substituted with up to two substituents selected from halo, C1-6alkyl or C1-6alkyloxy; the stereochemically isomeric forms thereof, and the pharmaceutically acceptable acid addition salts thereof. The present invention further comprises the pharmaceutical compositions comprising compounds of formula (I), the preparation thereof as well as the use as a medicine in the treatment of hyperlipidemia.
Patent NZ-330594-A (NZ)
Title: Container with engageable spout
Inventor: FINCH KELVIN WARREN MITCHELL
IPC: B65D39/08
Filed: 1998-06-05
Abstract: Firstly there is provided is a spout for a container of substantially cylindrical shape having a bore therethrough with a mouth region and a base region which is container engageable or engaged to provide in use (when engaged with the container) a sealed connection with the container, the spout comprising an annular flange formed externally to provide a threaded section between the annular flange and base, the spout adapted to be realeasably engageable with a) a first spout engaging means releasably enageable by rotational screw engagement with the screw thread means, and b) a second spout engaging means, releasably press engageable with the external annular flange, wherein the annular flange has a region of discontinuity through, which complimentary thread engaging means of the first spout engaging means, is able to pass.  Secondly there is provided a combination of a closure and a spout for a container wherein the spout comprises a cylindrical neck portion including a bore therethough and terminating having a mouth region and a base attachable or attached to a container providing a sealed connection with the container, an annular flange formed externally on the neck portion at or below the mouth region, an external screw threaded section between the annular flange and the base, and a closure releasably press engageable in the direction axial to the axis of the cylindrical neck portion, with the spout in at least two conditions:  a first condition where a bore locating portion of the closure releasably but securely locates with the spout within the bore, and in a second and axially more advanced condition where a frangibly detachable ring of the closure locates with a frangible detachable ring engageable flange disposed from the cylindrical neck portion between the tread region and the base, where the annular flange has a r4egion of discontinuity through which, a complimentary thread of a threaded spout engaging means to engage with the external thread is able to pass.
Patent NZ-331874-A (NZ)
Title: Arylamino fused pyridines and pyrimidines and their use in treating psychiatric and neurological diseases
Inventor: BAKTHAVATCHALAM RAJAGOPAL
IPC: A01N43/54
Filed: 1997-03-25
Abstract: These corticotropin releasing factor (CRF) antagonists are of formula (I) or formula (II) where X is N or CR; Y is N or CR; Z is NR, O or S(O)n ; G is O or S; Ar is a heterocyclic or carbocyclic aromatic ring system and R is variously as defined in the specification.  Also included is the use of these compounds for preparing compositions of treating in treating anxiety, depression, and other psychiatric and neurological disorders.
Patent NZ-503459-A (NZ)
Title: Organic acid addition salts of morphine alkaloids and use as transdermal or transmucosal agents
Inventor: KOCH ANDREAS
IPC: A61K47/10
Filed: 1998-09-05
Abstract: Transdermal or transmucosal composition for administering morphine alkaloids of formula (I), wherein: R1 is H or a C1-C6 alkyl residue; R2 is H, OH, OC(O)CH3, whereby in this case the fourth valence of the (6) -C atom is occupied by H, or the dyad residues =O, =CH2; R3 is -CH3, cyclopropyl, cyclobutyl or allyl The bond at C7/C8 may be saturated, or a N oxide group may be present at N17 The composition contains the morphine alkaloid as an acid addition salt of an organic acid which is selected from: -monoesters of C3-C16-dicarboxylic acids with monohydric C1-C4-alcohols, -C2-C6 and C8-C16-sulfonic acids, -halogen, p- or m- hydroxy, alkyl, hydroxyalkyl, alkoxyalkyl and/or alkoxy-substituted benzoic acids, which may optionally be alkylated at the N atom, -substituted or non-substituted 5-ring or 6-ring heterocycles comprising at least one N or S atom and having a carboxyl group function, -saturated or unsaturated, optionally substituted, oxocarboxylic acids having 5 to 10 carbon atoms, -phenoxy-substituted saturated C2-C4-carboxylic acids. -aliphatic, aromatic or heterocyclic C2-C12-amino acids, wherein one amino group is substituted with an optionally substituted -benzoyl group The acid addition salt possesses penetration behaviour with a flux of at least 2.34mg.cm2.h. The compositions described above are useful for formulating preparations for pain control or for withdrawal therapy of drug addicts.
Patent NZ-504558-A (NZ)
Title: Internal frustoconical support structure for a reel supporting optical fibres
Inventor: BOCCIOLA LORENZO
IPC: B65H75/14
Filed: 1998-11-04
Abstract: Reel for supporting optical fibres comprising a winding drum (2) having a tubular cylindrical shape, a pair of containing flanges (3), each of which is positioned close to one of the end edges (2a) of the said drum, a central core (6) positioned coaxially inside the winding drum (2) and at least one pair of interconnecting flanges (7) positioned either side of a transverse median plane (X-X) of the reel (1), each of which extends from the central core (6) to the winding drum (2). The said interconnecting flanges (7) are joined to the winding drum (2) at an attachment point (P) and to the central core at an anchor point (P'). This anchor point (P') is positioned closer to the transverse median plane (X-X) of the reel than is the attachment point (P) so as to form a given angle between the said interconnecting flange (7) and the core (6) such as to limit deformation of the containing flanges during rotation.
Patent NZ-511757-A (NZ)
Title: Assay for phosphatase-targeting toxins
Inventor: DOSKELAND STEIN OVE
IPC: G01N33/53
Filed: 1999-11-11
Abstract: An assay method for determining phosphatase targeting toxins, which inhibit protein phosphatases, comprising contacting a solid support having an immobilized ligand thereon with: (i) a sample suspected of being contaminated with toxin and (ii) a non-immobilized ligand, wherein said immobilized ligand is capable of binding to at least one of said toxins, to said nonimmobilized ligand or to complexes of said toxin and said non-immobilized ligand, and said non-immobilized ligand is capable of binding to at least one of said immobilized ligand, to said toxin or to complexes of said toxin and said immobilized ligand whereby the proportion of said immobilized ligand bound by said toxin, said non-immobilized ligand or complexes of said toxin and said non-immobilized ligand is dependent on the toxin content of said sample and wherein said immobilized ligand is capable of generating directly or indirectly detectable signal when uncomplexed, when complexed by said toxin, when complexed by a complex of said toxin and said nonimmobilized ligand or when complexed by said nonimmobilized ligand or said non-immobilized ligand is capable of generating a directly or indirectly detectable signal when uncomplexed or when complexed, separating a bound fraction from a non-bound fraction; and directly or indirectly determining the nonimmobilized ligand bound to the immobilized ligand (the bound fraction) or non- complexed in aqueous solution (the non-bound fraction); wherein the application of (i) and (ii) to the solid support may be performed separately, sequentially or simultaneously and if separately or sequentially, they can be performed in either order.
Patent NZ-512663-A (NZ)
Title: Novel exendin agonist formulations and methods of administration thereof
Inventor: YOUNG ANDREW
IPC: A61K9/14
Filed: 2000-01-14
Abstract: Exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake, and are buffered in pharmaceutical formulation so that the formulation has a pH of 3 to 7. Such pharmaceutical compositions also comprise an iso-osmolality modifier and a preservative.
Patent NZ-514889-A (NZ)
Title: Tinnitus rehabilitation device and method
Inventor: DAVIS PAUL BENJAMIN
IPC: A61B5/12
Filed: 2000-03-17
Abstract: A tinnitus method and device for providing relief to a person suffering from the disturbing effects of tinnitus is described. The method can be implemented entirely in software to spectrally modify an audio signal in accordance with a predetermined masking algorithm which modifies the intensity of the audio signal at selected frequencies. A predetermined masking algorithm is described which provides intermittent masking of the tinnitus wherein, at a comfortable listening level, during peaks of the audio signal the tinnitus is completely obscured, whereas during troughs the perception of the tinnitus occasionally emerges. In practice it has been found that such intermittent masking provides an immediate sense of relief, control and relaxation for the person, whilst enabling sufficient perception of the tinnitus for habituation and long term treatment to occur. Advantageously the predetermined masking algorithm is specifically tailored to the audiometric configuration of the person. For example, the masking algorithm may be partly tailored to the hearing loss characteristic of the person. A tinnitus rehabilitation device used in conjunction with a personal sound reproducing system is also described.
Patent NZ-515718-A (NZ)
Title: Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
Inventor: JENSENIUS JENS CHRISTIAN
IPC: A61P37/02
Filed: 2000-05-10
Abstract: Use of a composition comprising a mannan-binding lectin MBL) subunit for treating infections of individuals classified as (i) having deficiency of cellular components of the immune system, (ii) being at risk of acquiring an immunocompromised condition resulting from a medical treatment, (iii) having a serum level of MBL in excess of 50ng/ml serum.
Patent NZ-516024-A (NZ)
Title: Methods for predicting pregnancy outcome in a subject by hCG assay
Inventor: O'CONNOR JOHN
IPC: G01N33/53
Filed: 2000-05-12
Abstract: A method for detecting a problem pregnancy in a subject comprising the steps of: (a) (1) contacting a first portion of a sample from the subject with a first antibody which binds to the hCG isoform recognized by the B152 antibody; (2) contacting the sample resulting from (a)(1) with a second, labeled antibody which binds to the hCG isoform simultaneously with the first antibody; (3) measuring the amount of any bound second antibody in the sample to determine the amount of B152 detectable hCG in the sample; (b) (1) contacting a second portion of the sample from the subject with a third antibody which binds to intact, non-nicked hCG without substantially cross-reacting with nicked hCG, free hCGâ subunit, hCGâcf or hLH; (2) contacting the sample resulting from (b)(1) with a fourth, labeled antibody which binds to intact non-nicked hCHG simultaneously with the third antibody; (3) measuring the amount of bound fourth antibody in the sample, so as to thereby determine the amount of intact hCG in the sample, with the proviso that steps (a) and (b) may be performed in any order; (c) determining the ratio of B152-detectable hCG to intact hCG in the sample from the measurements performed in (a)(3) and (b)(3); (d) repeating steps (a)-(c) for samples taken from the subject over a period of several weeks, wherein the failure to detect a decrease in the ratio determined in step (c) compared with the amount of hCG determined in either of steps (a)(3) or (b)(3) indicates a problem pregnancy in the subject.
Patent NZ-516159-A (NZ)
Title: The use of the protein UK 114 inhibiting organ transplant rejection
Inventor: BARTORELLI ALBERTO
IPC: A61P37/06
Filed: 2000-06-19
Abstract: A protein UK 114 for the preparation of medicaments for reducing or inhibiting organ transplant rejection and for maintaining the acceptance of the transplant. A preferred use is preventing the rejection of Langerhans cells transplants.
Patent NZ-520268-A (NZ)
Title: Process for the preparation of peptides
Inventor: EGGEN IVO FRANCI
IPC: C07K1/10
Filed: 2002-07-18
Abstract: A process for the preparation of compounds containing one or more amide bonds using an excess of an activated carboxylic component to acylate an amino component, wherein after the acylation an amine comprising a free anion or a latent anion is used as a scavenger of residual activated carboxylic functions.
Patent NZ-520282-A (NZ)
Title: The use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
Inventor: EISENBACH-SCHWARTZ MICHAL
IPC: A61P25/28
Filed: 2001-01-22
Abstract: Discussed is the use of Cop 1 or a Cop 1-related peptide or polypeptide for the preparation of a medicament for treating neuronal degeneration caused by injury in the central nervous system (CNS) or peripheral nervous system (PNS). The aforementioned polypeptides can also be used in medicaments for the treatment of glutamate toxicity, wherein the said disease is not multiple sclerosis. Conditions that may be treated include Alzheimer's disease, Huntington's chorea, prion disease such as Creutzfeldt - Jakob disease, hypoglycemia and toxins.